The historical rank and industry rank for Nuo Therapeutics's FCF Margin % or its related term are showing as below:
AURX'
s FCF Margin % Range Over the Past 10 Years
Min: -3362.5 Med: -230.69 Max: -2.74
Current: -522.2
During the past 13 years, the highest FCF Margin % of Nuo Therapeutics was -2.74%. The lowest was -3362.50%. And the median was -230.69%.
AURX's FCF Margin % is ranked worse than 67.79% of 1040
companies
in the Biotechnology industry
Industry Median: -141.08
vs AURX: -522.20
Nuo Therapeutics FCF Margin % Historical Data
The historical data trend for Nuo Therapeutics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nuo Therapeutics's FCF Margin %
For the Biotechnology subindustry, Nuo Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuo Therapeutics's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nuo Therapeutics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Nuo Therapeutics's FCF Margin % falls into.
Nuo Therapeutics FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Nuo Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuo Therapeutics FCF Margin % Related Terms
Thank you for viewing the detailed overview of Nuo Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nuo Therapeutics (Nuo Therapeutics) Business Description
Nuo Therapeutics Inc is a regenerative therapies company focused on developing and marketing products for chronic wound care primarily within the U.S. Company's commercialize innovative cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The company derives revenues from the sale of the Aurix product to customers consisting of primarily hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The Aurix product became commercially available for sale in current financial year.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AURX has been successfully added to your 